1.
Stilgenbauer S, Morschhauser F, Wendtner C-M, Cartron G, Hallek M, Eichhorst B, Kozloff MF, Giever T, Lozanski G, Jiang Y, Huang H, Pignataro DS, Schary W, Humphrey K, Mobasher M, Salles G. Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440). Haematologica 2020;106(11):2834-2844; https://doi.org/10.3324/haematol.2020.261107.